Lisa Prosser
Marilyn Fisher Blanch Research Professor of Pediatrics
Associate Vice President for Research-Health Sciences and Research Faculty Affairs, Office of the Vice President for Research
Professor of Pediatrics, Medical School
Professor of Health Management and Policy, School of Public Health
[email protected]
Available to mentor
Lisa Prosser
Professor
Manage Your Profile
Center Memberships
-
Center MemberOpioid Research Institute
-
Center MemberCaswell Diabetes Institute
-
Center MemberInstitute for Healthcare Policy and Innovation
Recent Publications
-
Prosser LA, Hutton DW. JAMA Pediatr, 2026 Apr 13;Journal ArticleWhen Cost-Effectiveness Crosses Borders-Nirsevimab as an Example.
DOI:10.1001/jamapediatrics.2026.0823 PMID: 41973441 -
Matza LS, Rowen D, Chandler F, Dalziel K, Ghabri S, Law EH, Prosser LA, Rivero-Arias O, Shah K, Stolk E, Wolff J, Devlin N. Value in Health, 2026 Apr 1; 29 (4): 535 - 546.Journal ArticleValuing Child and Adolescent Health States to Derive Utilities for Use in Economic Evaluation: A Good Practices Report of an ISPOR Task Force
DOI:10.1016/j.jval.2025.12.016 PMID: 41581858 -
Johnson S, Nguyen HQ, Stockwell MS, Porucznik CA, Karron RA, Dawood FS, Prosser LA, Sarakki AP, Stanford JB, Hetrich M, Schappell E, Knoll MD, Veguilla V, Mellis A, Duque J, Jeddy Z, Pike J, Rolfes MA. 2025 Dec 13; medRxiv,PreprintEstimating Impact of SARS-CoV-2 Infection on Health-Related Quality of Life among Persons Aged 8 years and Older, August 2020-July 2022
DOI:10.64898/2025.12.10.25341971 -
Rose AM, Mercon KR, Gebremariam A, Pike J, Prosser LA. Cost Eff Resour Alloc, 2025 Aug 12; 23 (1): 42Journal ArticleOut-of-pocket costs, time burden, and caregiver quality of life associated with pediatric medically attended respiratory syncytial virus illnesses.
DOI:10.1186/s12962-025-00646-4 PMID: PMC12344828 -
Prosser LA, Wallace M, Rose AM, Mercon K, Janusz CB, Gebremariam A, Hutton DW, Leidner AJ, Zhou F, Ortega-Sanchez IR, Moulia D, Link-Gelles R, Saydah S, Shah M, Pike J. JAMA Netw Open, 2025 Aug 1; 8 (8): e2523688Journal ArticleCost-Effectiveness of 2023-2024 COVID-19 Vaccination in US Adults.
DOI:10.1001/jamanetworkopen.2025.23688 PMID: PMC12332627 -
Jacob V, Reynolds JA, Chattopadhyay SK, Hopkins DP, Peterson C, Tenney B, Nadal N, Cuellar AE, Prosser LA, Clymer JM, Stoddard SA. American Journal of Preventive Medicine, 2025 Jul 1; 69 (1):Journal ArticleFamily-Based Interventions to Prevent Substance Use Among Youth: Community Guide Systematic Economic Review
DOI:10.1016/j.amepre.2025.04.009 PMID: 40252864 -
Ream MA, Lam WKK, Grosse SD, Ojodu J, Jones E, Prosser LA, Rose AM, Comeau AM, Tanksley S, DiCostanzo KP, Kemper AR. Pediatrics, 2025 Apr 1; 155 (4):Journal ArticleEvidence and Recommendation for Infantile Krabbe Disease Newborn Screening
DOI:10.1542/peds.2024-069152 PMID: 40074005 -
Prosser LA, Perroud J, Chung GS, Gebremariam A, Janusz CB, Mercon K, Rose AM, Avañcena ALV, Kim DeLuca E, Hutton DW. Vaccine, 2025 Feb 27; 48:Journal ArticleThe cost-effectiveness of vaccination against COVID-19 illness during the initial year of vaccination
DOI:10.1016/j.vaccine.2025.126725 PMID: 39842151
Featured News & Stories
Health Lab
Broad COVID-19 vaccination makes economic sense, especially for older adults
COVID-19 vaccination of people over 65 would save the country money, and vaccination of younger groups of adults would be a reasonable investment
Health Lab
Investing in COVID-19 vaccination more than paid off for U.S.
The money spent to develop, test, buy and administer the first COVID-19 vaccine was more than made up for by prevented medical care and lost productivity.
